Use of bevacizumab after U.S. Food and Drug Administration (FDA) approval for first-line metastatic colorectal cancer (mCRC): A Cancer Outcomes Research & Surveillance Consortium (CanCORS) study


Journal Article

Full Text

Duke Authors

Cited Authors

  • Zafar, Y; Grambow, SC; Abbott, DH; Schrag, D; Kolimaga, JT; Conner, LZ; Weeks, JC; Provenzale, D

Published Date

  • May 20, 2008

Published In

Volume / Issue

  • 26 / 15_suppl

Start / End Page

  • 6562 - 6562

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2008.26.15_suppl.6562


  • en